According to internal sources who requested anonymity, multiple global pharmaceutical clients are closely monitoring Samsung Biologics’ ongoing labor-management conflict and have explicitly expressed ...
The chief of Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, said Friday its new biomedicine ...
Samsung Biologics CEO John Lim reveals 5th factory completion plans for next month Joonrim Samba expands global presence with ...
Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...
Samsung Biologics is planning more than 50 meetings with global big pharmaceutical companies at the upcoming DCAT Week 2025 ...
C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said ...
South Korean stocks finished markedly higher Monday led by gains of top-cap Samsung Electronics and other tech shares tracking their Wall Street peers despite lingering concerns about US President ...
Excluding the year 2020 when the event was not held due to COVID-19, Samsung Biologics has participated in DCAT Week for ten ...
Samsung Biologics, the biotech arm of Samsung Group, said Monday that it will participate in DCAT Week 2025, taking place March 17-20 in New York, as part of its efforts to expand its global business ...